Grace Eleojo Itodo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Grace Eleojo Itodo has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Seyi Samson Enitan
Department of Medical Laboratory Science, Babcock University, Ilishan-Remo, Ogun State, Nigeria
9 shared publications - Michael Unata Iduh
Department of Medical Microbiology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Sokoto State Nigeria
6 shared publications - Richard Akele
Department of Biomedical Science, School of Applied Science, University Of Brighton, London, United Kingdom
5 shared publications - Ayomide Oluwatobiloba Okuneye
Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo 121109, Ogun State, Nigeria
3 shared publications - Michael Olugbamila Dada
Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, 121109, Ogun State, Nigeria
3 shared publications - Ameh Raphael Adole
Department of Infectious disease, Clinton Health Access Initiative, FCT-Abuja, Nigeria
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Elsevier in Clinical Immunology Communications
- Vol. 10
Towards broadly protective hantavirus vaccine: Immunological barriers, structural vaccinology and one health perspectives
- 20 August 2026
- Published by Elsevier in Clinical Immunology Communications
- Vol. 10
Open AccessTowards broadly protective hantavirus vaccine: Immunological barriers, structural vaccinology and one health perspectives
- Open Access
- 31 March 2026
- Published by Narra Sains Indonesia in Narra Review
- Vol. 2 (1) , e18
When heat becomes a toxin: A narrative review on heatwaves, cardiac vulnerability, and population risk profiles in low- and middle-income countries
Climate change has intensified global heat exposure, particularly through more frequent and severe heatwaves. These conditions pose substantial risks to cardiovascular health. Low- and middle-income countries (LMICs) are disproportionately affected because of elevated baseline cardiovascular disease (CVD) burdens and limited adaptive capacity. The aim of this study was to synthesize epidemiological evidence linking extreme heat and heatwaves to CVD morbidity and mortality in LMICs, explore biological mechanisms underlying heat-induced cardiac stress, and examines social and environmental factors contributing to population vulnerability. Evidence from studies consistently demonstrates that extreme heat increases CVD events, with effect often emerging within 0–3 days following exposure. Proposed mechanisms include thermoregulatory strain, dehydration-related hemoconcentration, endothelial dysfunction, heightened sympathetic activation, and exacerbation of pre-existing CVD. Older adults, individuals with comorbidities, outdoor workers, and households with poor housing conditions are disproportionately affected. Despite established risks, most LMICs lack a structured heat-health protection system, clinical protocols for managing vulnerable cardiovascular patients during heatwaves, and labor protections for heat-exposed workers. Strengthening climate-resilient health systems and developing targeted preventive strategies are essential to mitigate rising cardiovascular risks associated with extreme heat in LMICs.
- 31 March 2026
- Published by Narra Sains Indonesia in Narra Review
- Vol. 2 (1) , e18
Open AccessWhen heat becomes a toxin: A narrative review on heatwaves, cardiac vulnerability, and population risk profiles in low- and middle-income countries
Climate change has intensified global heat exposure, particularly through more frequent and severe heatwaves. These conditions pose substantial risks to cardiovascular health. Low- and middle-income countries (LMICs) are disproportionately affected because of elevated baseline cardiovascular disease (CVD) burdens and limited adaptive capacity. The aim of this study was to synthesize epidemiological evidence linking extreme heat and heatwaves to CVD morbidity and mortality in LMICs, explore biological mechanisms underlying heat-induced cardiac stress, and examines social and environmental factors contributing to population vulnerability. Evidence from studies consistently demonstrates that extreme heat increases CVD events, with effect often emerging within 0–3 days following exposure. Proposed mechanisms include thermoregulatory strain, dehydration-related hemoconcentration, endothelial dysfunction, heightened sympathetic activation, and exacerbation of pre-existing CVD. Older adults, individuals with comorbidities, outdoor workers, and households with poor housing conditions are disproportionately affected. Despite established risks, most LMICs lack a structured heat-health protection system, clinical protocols for managing vulnerable cardiovascular patients during heatwaves, and labor protections for heat-exposed workers. Strengthening climate-resilient health systems and developing targeted preventive strategies are essential to mitigate rising cardiovascular risks associated with extreme heat in LMICs.
- Open Access
- 30 November 2025
- Published by Narra Sains Indonesia in Narra Review
- Vol. 1 (3) , e15
Predicting post-radiotherapy dysphagia in head and neck cancer: A narrative review of emerging artificial intelligence models
Head and neck cancer (HNC) remains a significant global health burden, particularly due to the high incidence of treatment-related complications such as dysphagia. Post-radiotherapy dysphagia not only impairs swallowing and nutritional status but also reduces quality of life and increases healthcare utilization. Conventional diagnostic approaches to identify patients at risk are often limited by delayed detection, variability in assessment methods, and insufficient predictive accuracy. Predictive modeling, including statistical, machine learning, and deep learning approaches, has emerged as a promising strategy to anticipate dysphagia risk before or during treatment. Techniques such as radiomics, imaging-based biomarkers, and multimodal machine learning models allow for early identification of high-risk patients, thereby enabling tailored interventions and preventive strategies. The aim of this review is to map the current landscape of predictive models for post-radiotherapy dysphagia in HNC patients, highlighting methodologies, applications, and clinical implications. A comprehensive literature search was performed across PubMed, Scopus, Web of Science, and Embase databases, including studies published up to February 3, 2025. Evidence indicates that predictive models, particularly those integrating machine learning and deep learning approaches, show potential in improving accuracy and timeliness of dysphagia risk prediction. However, challenges remain, including heterogeneity of patient data, limited external validation, and barriers to clinical integration. This review highlights the potential of predictive modeling to enhance individualized care in HNC patients and emphasizes the need for standardized methodologies, multicenter validation, and real-world implementation to optimize outcomes.
- 30 November 2025
- Published by Narra Sains Indonesia in Narra Review
- Vol. 1 (3) , e15
Open AccessPredicting post-radiotherapy dysphagia in head and neck cancer: A narrative review of emerging artificial intelligence models
Head and neck cancer (HNC) remains a significant global health burden, particularly due to the high incidence of treatment-related complications such as dysphagia. Post-radiotherapy dysphagia not only impairs swallowing and nutritional status but also reduces quality of life and increases healthcare utilization. Conventional diagnostic approaches to identify patients at risk are often limited by delayed detection, variability in assessment methods, and insufficient predictive accuracy. Predictive modeling, including statistical, machine learning, and deep learning approaches, has emerged as a promising strategy to anticipate dysphagia risk before or during treatment. Techniques such as radiomics, imaging-based biomarkers, and multimodal machine learning models allow for early identification of high-risk patients, thereby enabling tailored interventions and preventive strategies. The aim of this review is to map the current landscape of predictive models for post-radiotherapy dysphagia in HNC patients, highlighting methodologies, applications, and clinical implications. A comprehensive literature search was performed across PubMed, Scopus, Web of Science, and Embase databases, including studies published up to February 3, 2025. Evidence indicates that predictive models, particularly those integrating machine learning and deep learning approaches, show potential in improving accuracy and timeliness of dysphagia risk prediction. However, challenges remain, including heterogeneity of patient data, limited external validation, and barriers to clinical integration. This review highlights the potential of predictive modeling to enhance individualized care in HNC patients and emphasizes the need for standardized methodologies, multicenter validation, and real-world implementation to optimize outcomes.
- Open Access
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 191-203
Mpox Resurgence: Preventing a Potential Pandemic Through Lessons Learned From COVID-19 Experience and Future Research Directions
Mpox, declared a Public Health Emergency of International Concern by the World Health Organization (WHO), poses a growing global threat. The resurgence, driven by the highly transmissible and severe clade Ib strain from the Democratic Republic of the Congo, raises concerns about a potential pandemic. This narrative review aims to identify actionable strategies to mitigate the current Mpox outbreak by leveraging lessons from past health crises, particularly COVID-19, and to highlight future research priorities essential for global preparedness. A comprehensive literature review from 2018 to 2024 was conducted using Google Scholar, Scopus, and PubMed databases, focusing on Mpox transmission, vaccine efficacy, antiviral treatments, and public health responses. Our findings revealed that the resurgence of Mpox is fueled by viral evolution, ecological changes, and inadequate surveillance, exacerbated by inequitable healthcare access and insufficient public health infrastructure. While existing vaccines, such as Jynneos and ACAM2000, offer protection, their long-term efficacy and safety across diverse populations require further study. Antiviral treatments, including tecovirimat and brincidofovir, show promise but lack optimized care protocols and face challenges such as emerging resistance. Lessons from the COVID-19 response underscore the importance of enhancing global surveillance systems, strengthening healthcare infrastructure, ensuring equitable vaccine distribution, and fostering community engagement. Effective Mpox management also requires standardized treatment guidelines and the integration of genomic monitoring to track viral evolution and drug resistance. Urgent international collaboration is needed to avert a potential Mpox pandemic. Priorities include advancing research on long-term vaccine efficacy, optimizing antiviral therapies, and improving care for severe cases. Actionable recommendations include robust policies, sustainable funding, and global collaboration to strengthen pandemic preparedness and mitigate Mpox’s impact.
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 191-203
Open AccessMpox Resurgence: Preventing a Potential Pandemic Through Lessons Learned From COVID-19 Experience and Future Research Directions
Mpox, declared a Public Health Emergency of International Concern by the World Health Organization (WHO), poses a growing global threat. The resurgence, driven by the highly transmissible and severe clade Ib strain from the Democratic Republic of the Congo, raises concerns about a potential pandemic. This narrative review aims to identify actionable strategies to mitigate the current Mpox outbreak by leveraging lessons from past health crises, particularly COVID-19, and to highlight future research priorities essential for global preparedness. A comprehensive literature review from 2018 to 2024 was conducted using Google Scholar, Scopus, and PubMed databases, focusing on Mpox transmission, vaccine efficacy, antiviral treatments, and public health responses. Our findings revealed that the resurgence of Mpox is fueled by viral evolution, ecological changes, and inadequate surveillance, exacerbated by inequitable healthcare access and insufficient public health infrastructure. While existing vaccines, such as Jynneos and ACAM2000, offer protection, their long-term efficacy and safety across diverse populations require further study. Antiviral treatments, including tecovirimat and brincidofovir, show promise but lack optimized care protocols and face challenges such as emerging resistance. Lessons from the COVID-19 response underscore the importance of enhancing global surveillance systems, strengthening healthcare infrastructure, ensuring equitable vaccine distribution, and fostering community engagement. Effective Mpox management also requires standardized treatment guidelines and the integration of genomic monitoring to track viral evolution and drug resistance. Urgent international collaboration is needed to avert a potential Mpox pandemic. Priorities include advancing research on long-term vaccine efficacy, optimizing antiviral therapies, and improving care for severe cases. Actionable recommendations include robust policies, sustainable funding, and global collaboration to strengthen pandemic preparedness and mitigate Mpox’s impact.
- Open Access
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 182-190
Advancing Toward a Hepatitis C-Free World: Emerging Therapies, Persistent Challenges, and Future Prospects
Recent advancements in the treatment of hepatitis C virus (HCV) infection have significantly advanced the goal of achieving a hepatitis C-free world. The introduction of direct-acting antivirals (DAAs) has revolutionized treatment, offering over 95% cure rates, shorter treatment durations, and fewer side effects. Pan-genotypic regimens, such as sofosbuvir/velpatasvir, have further simplified treatment by being effective across all HCV genotypes. Despite these advancements, substantial challenges persist globally. An estimated 50 million people are living with chronic HCV worldwide, yet many remain undiagnosed, particularly in low- and middle-income countries, where there is limited healthcare infrastructure. High treatment costs further restrict access to these life-saving therapies. Reinfection rates remain high among certain populations, such as people who inject drugs (PWIDs), and stigma continues to deter individuals from seeking testing and treatment. To advance HCV elimination, future efforts must prioritize universal screening, affordable treatment, improved diagnostic technologies, and intensified research into vaccine development. Strengthened global and local collaboration is essential to overcome these challenges and reduce the global HCV burden.
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 182-190
Open AccessAdvancing Toward a Hepatitis C-Free World: Emerging Therapies, Persistent Challenges, and Future Prospects
Recent advancements in the treatment of hepatitis C virus (HCV) infection have significantly advanced the goal of achieving a hepatitis C-free world. The introduction of direct-acting antivirals (DAAs) has revolutionized treatment, offering over 95% cure rates, shorter treatment durations, and fewer side effects. Pan-genotypic regimens, such as sofosbuvir/velpatasvir, have further simplified treatment by being effective across all HCV genotypes. Despite these advancements, substantial challenges persist globally. An estimated 50 million people are living with chronic HCV worldwide, yet many remain undiagnosed, particularly in low- and middle-income countries, where there is limited healthcare infrastructure. High treatment costs further restrict access to these life-saving therapies. Reinfection rates remain high among certain populations, such as people who inject drugs (PWIDs), and stigma continues to deter individuals from seeking testing and treatment. To advance HCV elimination, future efforts must prioritize universal screening, affordable treatment, improved diagnostic technologies, and intensified research into vaccine development. Strengthened global and local collaboration is essential to overcome these challenges and reduce the global HCV burden.
- Open Access
- 20 November 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- p. 375-395
Combating Measles in Nigeria: Epidemiological Trends, Drivers, Barriers and Public Health Interventions
Measles remains a significant public health challenge in Nigeria, contributing to substantial morbidity and mortality among children despite the availability of effective vaccines. This narrative review aims to synthesize current literature on the epidemiological trends, drivers, barriers, and public health interventions related to measles control in Nigeria. A comprehensive search was conducted across Google Scholar, Scopus, and PubMed for articles published between 2008 and 2024. The search strategy utilized keywords such as “measles,” “Nigeria,” “epidemiology,” “vaccination,” and “public health interventions.” Articles were selected based on predetermined inclusion and exclusion criteria, focusing on studies that specifically addressed measles and its control measures in Nigeria. The review highlights fluctuating measles incidence with periodic outbreaks exacerbated by low immunization coverage, population displacement, and rapid urbanization. Suboptimal vaccination rates for both the first (MCV1) and second (MCV2) doses leave many children vulnerable. Barriers to effective control include misinformation, vaccine hesitancy, insecurity in conflict-affected regions, and logistical challenges in vaccine distribution. Public health interventions, including enhanced immunization campaigns, community engagement, and integrated health services, are essential for improving vaccination coverage and combating measles. Achieving effective measles control in Nigeria requires sustained commitment, adequate funding, and international collaboration to ensure the health and well-being of Nigerian children.
- 20 November 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- p. 375-395
Open AccessCombating Measles in Nigeria: Epidemiological Trends, Drivers, Barriers and Public Health Interventions
Measles remains a significant public health challenge in Nigeria, contributing to substantial morbidity and mortality among children despite the availability of effective vaccines. This narrative review aims to synthesize current literature on the epidemiological trends, drivers, barriers, and public health interventions related to measles control in Nigeria. A comprehensive search was conducted across Google Scholar, Scopus, and PubMed for articles published between 2008 and 2024. The search strategy utilized keywords such as “measles,” “Nigeria,” “epidemiology,” “vaccination,” and “public health interventions.” Articles were selected based on predetermined inclusion and exclusion criteria, focusing on studies that specifically addressed measles and its control measures in Nigeria. The review highlights fluctuating measles incidence with periodic outbreaks exacerbated by low immunization coverage, population displacement, and rapid urbanization. Suboptimal vaccination rates for both the first (MCV1) and second (MCV2) doses leave many children vulnerable. Barriers to effective control include misinformation, vaccine hesitancy, insecurity in conflict-affected regions, and logistical challenges in vaccine distribution. Public health interventions, including enhanced immunization campaigns, community engagement, and integrated health services, are essential for improving vaccination coverage and combating measles. Achieving effective measles control in Nigeria requires sustained commitment, adequate funding, and international collaboration to ensure the health and well-being of Nigerian children.
- Open Access
- 14 October 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
Prevalence of Chikungunya Virus IgG and IgM Antibodies among Febrile Patients Presumptively Diagnosed with Malaria in Ogun State, Nigeria
Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.
- 14 October 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
Open AccessPrevalence of Chikungunya Virus IgG and IgM Antibodies among Febrile Patients Presumptively Diagnosed with Malaria in Ogun State, Nigeria
Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.
- Open Access
- 13 September 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-15
Molecular detection of OXA-48 and NDM-1 carbapenemase genes among clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria
There have been increasing reports of Klebsiella pneumoniae resistant to β-lactam antibiotics. This study aimed to determine the prevalence of some selected carbapenemase genes among clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria. The study was conducted over two months (February-March 2024). A total of 50 clinical isolates of Klebsiella pneumoniae from different clinical specimens were obtained from the Medical Microbiology Department, Babcock University Teaching Hospital (BUTH). The clinical isolates were then characterized using standard microbiological procedures and were tested for susceptibility to meropenem and other classes of antibiotics according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Polymerase Chain Reaction (PCR) detection for OXA-48 and NDM-1 carbapenemase genes was performed on the 50 clinical isolates. PCR analysis showed that 9 (18%) clinical isolates were positive for the OXA-48 gene, 22 (44%) were positive for the NDM-1 gene, 4 (8%) possessed both the OXA-48 and NDM-1 genes, and 23 (46%) possessed neither the OXA-48 nor NDM-1 genes. Antibiotic Susceptibility Testing (AST) revealed that all the clinical isolates were resistant to meropenem. In conclusion, this study demonstrates the presence of OXA-48 and NDM-1 genes in clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria, highlighting the role of ESBL (extended-spectrum beta-lactamase) as a major resistance mechanism alongside other mechanisms. Population-based surveillance programs should be implemented to monitor the prevalence and epidemiology of Klebsiella pneumoniae infections at the community level, facilitating early detection of outbreaks and identification of emerging antimicrobial resistance patterns. This study highlights the significant prevalence of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae clinical isolates in a private tertiary hospital in Southwestern Nigeria, with 44% and 18% of isolates harboring these genes, respectively. Notably, 46% of isolates were resistant to carbapenems despite lacking these genes, suggesting alternative resistance mechanisms. The findings underscore the urgent need for enhanced surveillance, infection control measures, and antibiotic stewardship programs to combat the spread of multidrug-resistant Klebsiella pneumoniae in healthcare settings.
- 13 September 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-15
Open AccessMolecular detection of OXA-48 and NDM-1 carbapenemase genes among clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria
There have been increasing reports of Klebsiella pneumoniae resistant to β-lactam antibiotics. This study aimed to determine the prevalence of some selected carbapenemase genes among clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria. The study was conducted over two months (February-March 2024). A total of 50 clinical isolates of Klebsiella pneumoniae from different clinical specimens were obtained from the Medical Microbiology Department, Babcock University Teaching Hospital (BUTH). The clinical isolates were then characterized using standard microbiological procedures and were tested for susceptibility to meropenem and other classes of antibiotics according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Polymerase Chain Reaction (PCR) detection for OXA-48 and NDM-1 carbapenemase genes was performed on the 50 clinical isolates. PCR analysis showed that 9 (18%) clinical isolates were positive for the OXA-48 gene, 22 (44%) were positive for the NDM-1 gene, 4 (8%) possessed both the OXA-48 and NDM-1 genes, and 23 (46%) possessed neither the OXA-48 nor NDM-1 genes. Antibiotic Susceptibility Testing (AST) revealed that all the clinical isolates were resistant to meropenem. In conclusion, this study demonstrates the presence of OXA-48 and NDM-1 genes in clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria, highlighting the role of ESBL (extended-spectrum beta-lactamase) as a major resistance mechanism alongside other mechanisms. Population-based surveillance programs should be implemented to monitor the prevalence and epidemiology of Klebsiella pneumoniae infections at the community level, facilitating early detection of outbreaks and identification of emerging antimicrobial resistance patterns. This study highlights the significant prevalence of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae clinical isolates in a private tertiary hospital in Southwestern Nigeria, with 44% and 18% of isolates harboring these genes, respectively. Notably, 46% of isolates were resistant to carbapenems despite lacking these genes, suggesting alternative resistance mechanisms. The findings underscore the urgent need for enhanced surveillance, infection control measures, and antibiotic stewardship programs to combat the spread of multidrug-resistant Klebsiella pneumoniae in healthcare settings.
- Open Access
- 18 October 2022
- Published by SASPR Edu International Pvt. Ltd in Scholars International Journal of Traditional and Complementary Medicine
- Vol. 5 (9) , 175-183
Phytochemical Screening, Proximate Analysis and Microbiological Quality of Bio-Clean II Herbal Remedy
- 18 October 2022
- Published by SASPR Edu International Pvt. Ltd in Scholars International Journal of Traditional and Complementary Medicine
- Vol. 5 (9) , 175-183
Open AccessPhytochemical Screening, Proximate Analysis and Microbiological Quality of Bio-Clean II Herbal Remedy
- Open Access
- 28 September 2022
- Published by Qeios Ltd in Qeios Preprints
Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria
BACKGROUND: Vaccination efforts against the Coronavirus Disease 2019 (COVID-19) pandemic may be hampered by vaccine hesitancy. This study assessed the acceptance rate of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria. METHODS: This web-based study was conducted among a selected Nigerian population between the month of February and May, 2021 using an online self-administered structured questionnaire hosted by Survey Monkey. WhatsApp, Twitter and Facebook were used to disseminate the invitation to take the poll. Data collected were analyzed using Statistical Package for Social Sciences Version 25 with level of significance set at P51 years and above) had the least vaccine acceptance rate (3.3%) at 75% vaccine efficacy and 20% side effect. Respondents who held the belief that vaccinations are essential for their health had higher chance to accept COVID-19 vaccine with OR: 0.76; 50%CI (0.00-0.00), OR: 6.31; 95%CI (0.000-0.000), OR: 1.23; 95%CI (0.193-7.860) and OR: 0.696; 95%CI (0.048-10.047) based on religion, occurrence of diabetes, Pulmonary disease and Hypertension, respectively. CONCLUSION: The results of this research indicate that vaccine acceptance rates are negatively correlated with participants' ages.
- 28 September 2022
- Published by Qeios Ltd in Qeios Preprints
Open AccessAcceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria
BACKGROUND: Vaccination efforts against the Coronavirus Disease 2019 (COVID-19) pandemic may be hampered by vaccine hesitancy. This study assessed the acceptance rate of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria. METHODS: This web-based study was conducted among a selected Nigerian population between the month of February and May, 2021 using an online self-administered structured questionnaire hosted by Survey Monkey. WhatsApp, Twitter and Facebook were used to disseminate the invitation to take the poll. Data collected were analyzed using Statistical Package for Social Sciences Version 25 with level of significance set at P51 years and above) had the least vaccine acceptance rate (3.3%) at 75% vaccine efficacy and 20% side effect. Respondents who held the belief that vaccinations are essential for their health had higher chance to accept COVID-19 vaccine with OR: 0.76; 50%CI (0.00-0.00), OR: 6.31; 95%CI (0.000-0.000), OR: 1.23; 95%CI (0.193-7.860) and OR: 0.696; 95%CI (0.048-10.047) based on religion, occurrence of diabetes, Pulmonary disease and Hypertension, respectively. CONCLUSION: The results of this research indicate that vaccine acceptance rates are negatively correlated with participants' ages.